PGX-Thrombo StripAssay®
Oral Anticoagulant Response Genotyping
The PGX-Thrombo StripAssay® identifies individuals who may have adverse reactions to vitamin K antagonists (coumarins) used in stroke prevention, enabling safer anticoagulation therapy through personalized dosing.
Key Features
Anticoagulant Adverse Reaction Screening
Identifies individuals at risk of adverse reactions to vitamin K antagonists used in stroke prevention.
Warfarin Dose Guidance
Supports optimization of anticoagulant dosing by identifying genetic variants affecting coumarin metabolism.
Stroke Prevention Safety
Enables safer anticoagulation therapy for stroke patients by flagging those at risk of adverse drug responses.
PCR & Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for reliable pharmacogenomic genotyping.
For Research Use Only (RUO)
PGX-Thrombo StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.